Insights

Partnership Potential Sage Therapeutics has recently partnered with Biogen Inc. to develop and commercialize a new drug, Zurzuvae. This partnership presents an opportunity for collaborative sales efforts with Biogen's existing network and potential expansion of Sage's customer base.

Investment Attraction Investments from companies like Quest Partners LLC and Algert Global LLC indicate external confidence in Sage Therapeutics. Leveraging this investor interest can be beneficial in attracting further funding or engaging in strategic partnerships for sales growth.

Technological Advantage Sage Therapeutics utilizes a robust tech stack including Amazon CloudFront, Cloudera, and Java. This focus on technology highlights the company's readiness for innovative sales strategies, such as leveraging data analytics for targeted marketing and sales campaigns.

Market Recognition Sage Therapeutics' recognition for its work on Mild Cognitive Impairment in Parkinson's Disease positions the company as a thought leader in neurology. This recognition can translate into increased credibility, potentially opening doors for sales collaborations with other industry leaders.

Diversified Product Portfolio With the recent launch of CNP and the Phase 2 study of dalzanemdor, Sage Therapeutics is diversifying its product offerings. This expansion of the product portfolio creates multiple sales opportunities in different segments of the market, allowing for broader revenue streams.

Sage Therapeutics Tech Stack

Sage Therapeutics uses 8 technology products and services including Amazon CloudFront, TrackWise Digital, Cloudera, and more. Explore Sage Therapeutics's tech stack below.

  • Amazon CloudFront
    Content Delivery Network
  • TrackWise Digital
    Data Quality Management
  • Cloudera
    Database
  • Okta
    Identity Verification
  • Aurelia
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • Java
    Programming Languages
  • Conga Contracts
    Sales

Media & News

Sage Therapeutics's Email Address Formats

Sage Therapeutics uses at least 1 format(s):
Sage Therapeutics Email FormatsExamplePercentage
first.last@sagerx.comJohn.Doe@sagerx.com
90%
first@sagerx.comJohn@sagerx.com
7%
first.middle@sagerx.comJohn.Michael@sagerx.com
2%
first.l@sagerx.comJohn.D@sagerx.com
1%

Frequently Asked Questions

Where is Sage Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Sage Therapeutics's main headquarters is located at 215 First Street Cambridge, MA 02142 US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Sage Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Sage Therapeutics's main corporate office by phone at +1-617-299-8380. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Sage Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Sage Therapeutics is a publicly traded company; the company's stock symbol is SAGE.

What is Sage Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Sage Therapeutics's official website is sagerx.com and has social profiles on LinkedIn.

How much revenue does Sage Therapeutics generate?

Minus sign iconPlus sign icon
As of May 2024, Sage Therapeutics's annual revenue reached $75M.

What is Sage Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Sage Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Sage Therapeutics have currently?

Minus sign iconPlus sign icon
As of May 2024, Sage Therapeutics has approximately 611 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Technology & Innovation Officer: M. L.Chief People & Experience Officer: E. L.Chief Enterprise Risk And Compliance Officer, Svp: D. K.. Explore Sage Therapeutics's employee directory with LeadIQ.

What industry does Sage Therapeutics belong to?

Minus sign iconPlus sign icon
Sage Therapeutics operates in the Biotechnology Research industry.

What technology does Sage Therapeutics use?

Minus sign iconPlus sign icon
Sage Therapeutics's tech stack includes Amazon CloudFrontTrackWise DigitalClouderaOktaAureliajQuery MigrateJavaConga Contracts.

What is Sage Therapeutics's email format?

Minus sign iconPlus sign icon
Sage Therapeutics's email format typically follows the pattern of . Find more Sage Therapeutics email formats with LeadIQ.

How much funding has Sage Therapeutics raised to date?

Minus sign iconPlus sign icon
As of May 2024, Sage Therapeutics has raised $650M in funding. The last funding round occurred on Nov 27, 2020.

When was Sage Therapeutics founded?

Minus sign iconPlus sign icon
Sage Therapeutics was founded in 2010.
Sage Therapeutics

Sage Therapeutics

Biotechnology ResearchMassachusetts, United States201-500 Employees

Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and change how brain disorders are thought about and treated. Our mission is to pioneer solutions with the potential to deliver life-changing brain health medicines, so every person can thrive.

Welcome To The Workplace With A Difference
At Sage, we believe that life is more than just a destination. We’re concerned with the journey, and we care deeply about everyone contributing to and benefiting from our own company journey. This means helping people discover the right path for them and carefully guiding colleagues along the way.

Read our Community Guidelines: http://bit.ly/2tFyAoj

Section iconCompany Overview

Headquarters
215 First Street Cambridge, MA 02142 US
Phone number
+1-617-299-8380
Website
sagerx.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
SAGE
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2010
Employees
201-500

Section iconFunding & Financials

  • $650M

    Sage Therapeutics has raised a total of $650M of funding over 10 rounds. Their latest funding round was raised on Nov 27, 2020.

  • $50M$100M

    Sage Therapeutics's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $650M

    Sage Therapeutics has raised a total of $650M of funding over 10 rounds. Their latest funding round was raised on Nov 27, 2020.

  • $50M$100M

    Sage Therapeutics's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.